Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page footer’s revision/build version was updated from v3.5.2 to v3.5.3, reflecting a platform change rather than any change to the clinical trial’s content.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Medullary thyroid carcinoma as a disease reference. Included the Genetic and Rare Diseases Information Center as a Resources entry.SummaryDifference0.2%

- Check38 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check45 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 was added, and prior government-funding notices as well as Revision: v3.4.1 were removed. This change does not affect study content, eligibility criteria, or results.SummaryDifference0.5%

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.